BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31677800)

  • 21. Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients.
    Taura K; Ikai I; Hatano E; Yasuchika K; Nakajima A; Tada M; Seo S; Machimoto T; Uemoto S
    Surgery; 2007 Nov; 142(5):685-94. PubMed ID: 17981188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China.
    Xu XF; Xing H; Han J; Li ZL; Lau WY; Zhou YH; Gu WM; Wang H; Chen TH; Zeng YY; Li C; Wu MC; Shen F; Yang T
    JAMA Surg; 2019 Mar; 154(3):209-217. PubMed ID: 30422241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic resection versus operative microwave ablation for single hepatocellular carcinoma ≤5 cm: A propensity score-matched analysis.
    Ryu T; Takami Y; Wada Y; Hara T; Sasaki S; Saitsu H
    Surgery; 2019 Sep; 166(3):254-262. PubMed ID: 31279438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatectomy versus stereotactic body radiotherapy for primary early hepatocellular carcinoma: A propensity-matched analysis in a single institution.
    Nakano R; Ohira M; Kobayashi T; Ide K; Tahara H; Kuroda S; Shimizu S; Kimura T; Nagata Y; Aikata H; Chayama K; Ohdan H
    Surgery; 2018 Aug; 164(2):219-226. PubMed ID: 29801728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patients.
    Tsilimigras DI; Bagante F; Moris D; Merath K; Paredes AZ; Sahara K; Ratti F; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
    Surgery; 2019 Dec; 166(6):967-974. PubMed ID: 31606196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sorafenib vs surgical resection for hepatocellular carcinoma with macrovascular invasion: A propensity score analysis.
    Costentin CE; Decaens T; Laurent A; Nault JC; Paule B; Letoublon C; Luciani A; Calderaro J; Adam R; Bricault I; Amaddeo G; Cherqui D; Mallat A; Samuel D; Duvoux C; Ganne-Carrié N; Roudot-Thoraval F; Vibert E
    Liver Int; 2017 Dec; 37(12):1869-1876. PubMed ID: 28609020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcomes after hepatectomy of huge hepatocellular carcinoma: A single-center experience in China.
    Fang Q; Xie QS; Chen JM; Shan SL; Xie K; Geng XP; Liu FB
    Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):532-537. PubMed ID: 31543313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiofrequency ablation is better than surgical resection in patients with hepatocellular carcinoma within the Milan criteria and preserved liver function: a retrospective study using propensity score analyses.
    Lee YH; Hsu CY; Chu CW; Liu PH; Hsia CY; Huang YH; Su CW; Chiou YY; Lin HC; Huo TI
    J Clin Gastroenterol; 2015 Mar; 49(3):242-9. PubMed ID: 24714185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No impact of perioperative blood transfusion on prognosis after curative resection for hepatocellular carcinoma: a propensity score matching analysis.
    Peng T; Zhao G; Wang L; Wu J; Cui H; Liang Y; Zhou R; Liu Z; Wang Q
    Clin Transl Oncol; 2018 Jun; 20(6):719-728. PubMed ID: 29080121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do patients with small solitary hepatocellular carcinomas without macroscopically vascular invasion require anatomic resection? Propensity score analysis.
    Hirokawa F; Kubo S; Nagano H; Nakai T; Kaibori M; Hayashi M; Takemura S; Wada H; Nakata Y; Matsui K; Ishizaki M; Uchiyama K
    Surgery; 2015 Jan; 157(1):27-36. PubMed ID: 25482463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Singapore Liver Cancer Recurrence (SLICER) Score for relapse prediction in patients with surgically resected hepatocellular carcinoma.
    Ang SF; Ng ES; Li H; Ong YH; Choo SP; Ngeow J; Toh HC; Lim KH; Yap HY; Tan CK; Ooi LL; Cheow PC; Chung AY; Chow PK; Foo KF; Tan MH
    PLoS One; 2015; 10(4):e0118658. PubMed ID: 25830231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
    Shimozawa N; Hanazaki K
    J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of anatomic and non-anatomic hepatic resection for hepatocellular carcinoma.
    Kaibori M; Kon M; Kitawaki T; Kawaura T; Hasegawa K; Kokudo N; Ariizumi S; Beppu T; Ishizu H; Kubo S; Kamiyama T; Takamura H; Kobayashi T; Kim DS; Wang HJ; Kim JM; Han DH; Park SJ; Kang KJ; Hwang S; Roh Y; You YK; Joh JW; Yamamoto M
    J Hepatobiliary Pancreat Sci; 2017 Nov; 24(11):616-626. PubMed ID: 28887834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term survival after resection of hepatocelluar carcinoma: a potential risk associated with the choice of postoperative analgesia.
    Cao L; Chang Y; Lin W; Zhou J; Tan H; Yuan Y; Zeng W
    Anesth Analg; 2014 Jun; 118(6):1309-16. PubMed ID: 24842178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical resection versus ablation for hepatocellular carcinoma ≤ 3 cm: a population-based analysis.
    Miura JT; Johnston FM; Tsai S; Eastwood D; Banerjee A; Christians KK; Turaga KK; Gamblin TC
    HPB (Oxford); 2015 Oct; 17(10):896-901. PubMed ID: 26228076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accompanying liver cirrhosis as a risk factor for recurrence after resection of solitary hepatocellular carcinoma.
    Takada Y; Otsuka M; Todoroki T; Fukao K
    Hepatogastroenterology; 2003; 50(54):1991-5. PubMed ID: 14696450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients.
    Giannini EG; Savarino V; Farinati F; Ciccarese F; Rapaccini G; Marco MD; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
    Liver Int; 2013 Nov; 33(10):1594-600. PubMed ID: 23654354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.
    Zhao WH; Ma ZM; Zhou XR; Feng YZ; Fang BS
    World J Gastroenterol; 2002 Apr; 8(2):237-42. PubMed ID: 11925599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver Resection for Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma.
    Koh YX; Tan HJ; Liew YX; Syn N; Teo JY; Lee SY; Goh BKP; Goh GBB; Chan CY
    J Am Coll Surg; 2019 Nov; 229(5):467-478.e1. PubMed ID: 31398386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Forns index predicts recurrence and death in patients with hepatitis B-related hepatocellular carcinoma after curative resection.
    Choi WM; Lee JH; Ahn H; Cho H; Cho YY; Lee M; Yoo JJ; Cho Y; Lee DH; Lee YB; Cho EJ; Yu SJ; Yi NJ; Lee KW; Kim YJ; Yoon JH; Suh KS; Kim CY; Lee HS
    Liver Int; 2015 Aug; 35(8):1992-2000. PubMed ID: 25556714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.